A Phase III protocol comparing Panretin to tretinoin (Vesinoid) to treat APL has appeared. The following centers are participating:
George Ross Langley, Principal Investigator, Ph: 902-428-2107
Victoria General Hospital
Halifax, Nova Scotia, Canada
Wilson Miller, Jr., Principal Investigator, Ph: 514-340-8248
Jewish General Hospital
Montreal, Quebec, Canada
Raymond Taetle, Principal Investigator, Ph: 520-626-7228
Arizona Cancer Center
Tucson, Arizona, USA
Arturo Molina, Principal Investigator, Ph: 818-359-8111 ext 3973
Beckman Research Institute of the City of Hope
Duarte, California, USA
Dorothy Park, Principal Investigator, Ph: 310-855-4502
Cedars-Sinai Medical Center
Los Angeles, California, USA
Anthony D. Ho, Principal Investigator, Ph: 619-822-0400
University of California San Diego Cancer Center - La Jolla
La Jolla, California, USA
Dan Douer, Principal Investigator, Ph: 213-764-3950
USC/Norris Comprehensive Cancer Center
Los Angeles, California, USA
Stanley Raban Frankel, Principal Investigator, Ph: 202-687-2242
Vincent T. Lombardi Cancer Research Center, Georgetown University Medical Center
Washington, District of Columbia, USA
Martin Stuart Tallman, Principal Investigator, Ph: 312-908-8697
Northwestern University Robert H. Lurie Cancer Center
Chicago, Illinois, USA
Larry D. Cripe, Principal Investigator, Ph: 317-274-3545
Indiana University Cancer Center
Indianapolis, Indiana, USA
Glenn M. Mills, Principal Investigator, Ph: 318-675-5970
Louisiana State University Hospital - Shreveport
Shreveport, Louisiana, USA
Kenneth B. Miller, Principal Investigator, Ph: 617-956-5144
New England Medical Center
Boston, Massachusetts, USA
Laurence Elias, Principal Investigator, Ph: 505-277-5837
University of New Mexico Cancer Research & Treatment Center
Albuquerque, New Mexico, USA
Peter H. Wiernik, Principal Investigator, Ph: 718-920-4826
Albert Einstein Cancer Research Center - Bronx
Bronx, New York, USA
Raymond Paul Warrell, Jr., Principal Investigator, Ph: 212-639-8168
Memorial Sloan-Kettering Cancer Center
New York, New York, USA
Janet Cuttner, Principal Investigator, Ph: 212-241-6481
Mount Sinai Medical Center, NY
New York, New York, USA
Thomas C. Shea, Principal Investigator, Ph: 919-966-7746
Lineberger Comprehensive Cancer Center UNC
Chapel Hill, North Carolina, USA
Brenda W. Cooper, Principal Investigator, Ph: 216-844-3213
Case Western Reserve University/Ireland Cancer Center
Cleveland, Ohio, USA
William S. Velasquez, Principal Investigator, Ph: 409-772-1164
University of Texas Medical Branch
Galveston, Texas, USA |
